Professor | Xiaoyang Zhou | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xiaoyang Zhou
Contact Information	xiaoyangzh@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Xiaoyang Zhou

Contact Information

xiaoyangzh@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1986.09-1991.06 Bachelor of Clinical Medicine from Wuhan University 1995.09-1998.06 Master of Internal Medicine from Wuhan University 2001.09-2004.06 PhD in Cardiovascular Clinical Epidemiology from Peking Union Medical College Hospital Published over 80 papers, including more than 50 SCI papers Edited 6 books and contributed to 9 guidelines/consensus Received 4 invention patents Awarded second and third prizes in Hubei Province Science and Technology Progress
Work Experience	1991.07-1995.06 Resident Physician at Tongji Medical College, Huazhong University of Science and Technology 1998.07-2001.06 Resident Physician, Attending Physician (1999) at Wuhan University, Zhongnan Hospital 1999.07-2000.07 Advanced Studies in Emergency Department at PLA General Hospital 2005.01-2005.06 Postdoctoral Research at Oregon Health & Science University, USA 2005.06-2008.01 Postdoctoral Research at University of Cincinnati, USA 2004.07-present Associate Chief Physician (2004), Associate Professor (2005), Chief Physician (2019) at Renmin Hospital, Wuhan University 2014.08-2017.08 Director of General Medicine Department, Renmin Hospital East Campus, Wuhan University 2017.09-present Director of CCU and Deputy Director of Cardiology Department, Renmin Hospital East Campus, Wuhan University
Awards	2020: Innovation Award in Medical Application from People's Daily for 'Kangkang Shengshi' remote dynamic blood pressure monitoring system during COVID-19 2020: Anti-epidemic Hero Award from the Chinese Society of Cardiology 2020: Advanced Individual in Fighting COVID-19 from the Central Committee of the China Democratic League 2020: Anti-epidemic Pioneer from the Hubei Provincial Committee of the China Democratic League 2021: Second Prize in Hubei Province Science and Technology Progress for 'Illustrated Virus'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1986.09-1991.06 Bachelor of Clinical Medicine from Wuhan University
1995.09-1998.06 Master of Internal Medicine from Wuhan University
2001.09-2004.06 PhD in Cardiovascular Clinical Epidemiology from Peking Union Medical College Hospital
Published over 80 papers, including more than 50 SCI papers
Edited 6 books and contributed to 9 guidelines/consensus
Received 4 invention patents
Awarded second and third prizes in Hubei Province Science and Technology Progress

Work Experience

1991.07-1995.06 Resident Physician at Tongji Medical College, Huazhong University of Science and Technology
1998.07-2001.06 Resident Physician, Attending Physician (1999) at Wuhan University, Zhongnan Hospital
1999.07-2000.07 Advanced Studies in Emergency Department at PLA General Hospital
2005.01-2005.06 Postdoctoral Research at Oregon Health & Science University, USA
2005.06-2008.01 Postdoctoral Research at University of Cincinnati, USA
2004.07-present Associate Chief Physician (2004), Associate Professor (2005), Chief Physician (2019) at Renmin Hospital, Wuhan University
2014.08-2017.08 Director of General Medicine Department, Renmin Hospital East Campus, Wuhan University
2017.09-present Director of CCU and Deputy Director of Cardiology Department, Renmin Hospital East Campus, Wuhan University

Awards

2020: Innovation Award in Medical Application from People's Daily for 'Kangkang Shengshi' remote dynamic blood pressure monitoring system during COVID-19
2020: Anti-epidemic Hero Award from the Chinese Society of Cardiology
2020: Advanced Individual in Fighting COVID-19 from the Central Committee of the China Democratic League
2020: Anti-epidemic Pioneer from the Hubei Provincial Committee of the China Democratic League
2021: Second Prize in Hubei Province Science and Technology Progress for 'Illustrated Virus'

Areas of Focus	Hypertension Cardiomyopathy and heart failure Cardiovascular metabolism
Publications	Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment, Ganesh S, Zhong P, Zhou X, 2022 Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages, Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, Yuan X, Liu L, Yang J, Zhou X, 2022 Additional Value of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events in Patients With Novel Coronavirus Disease 2019 (COVID-19), Li S, Wang X, Hu H, Xu J, He J, Yang W, He B, Liu Y, Yu H, Zhou Q, Zhang H, Liu T, Hu K, Zhao Y, Huang Z, Zhu H, Zhang B, Zhao S, Sirajuddin A, Arai AE, Chen J, Zhou X, Lu M, 2021 The prognostic value of myocardial injury in COVID-19 patients and associated characteristics, He J, Zhang B, Zhou Q, Yang W, Xu J, Liu T, Zhang H, Wu Z, Li D, Zhou Q, Yan J, Zhang C, Qian H, Lu M, Zhou X, 2021 Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application, Zhang S, Zhou X, Chen Y, Wang L, Zhu B, Jiang Y, Bu P, Liu W, Li D, Li Y, Tao Y, Ren J, Fu L, Li Y, Shen X, Liu H, Sun G, Xu X, Bai J, Zhang W, Cai J, 2021 Effects of the total physical activity and its changes on incidence, progression, and remission of hypertension, Cai C, Liu FC, Li JX, Huang KY, Yang XL, Chen JC, Liu XQ, Cao J, Chen SF, Shen C, Yu L, Lu FH, Wu XP, Zhao LC, Li Y, Hu DS, Huang JF, Zhou XY, Lu XF, Gu DF, 2021 Relationship between the ABO Blood Group and the COVID-19 Susceptibility, Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG, 2021 Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients, Wu Z, Hu R, Zhang C, Ren W, Yu A, Zhou X, 2020 Clinical characteristics of 82 cases of death from COVID-19, Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, Song Q, Jia Q, Wang J, 2020 Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19, Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B, Wang J, 2020 Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity, Liu Y, Duan C, Liu W, Chen X, Wang Y, Liu X, Yue J, Yang J, Zhou X, 2019 Glabridin prevents Doxorubicin-induced cardiotoxicity through gut microbiota modulation and colonic macrophage polarization in mice, Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X, 2019 Frontline Science: Reprogramming COX-2, 5-LOX, and CYP4A-mediated arachidonic acid metabolism in macrophages by salidroside alleviates gouty arthritis, Liu Y, Tang H, Liu X, Chen H, Feng N, Zhang J, Wang C, Qiu M, Yang J, Zhou X, 2019 Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis, Chen G, Zhou X, Florea S, Qian J, Cai W, Zhang Z, Fan GC, Lorenz J, Hajjar RJ, Kranias EG, 2010 The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure, Chen G, Zhou X, Pathak A, Dorn GW, Kranias EG, 2009 Overexpression of histidine-rich ca-binding protein protects against ischemia/reperfusion-induced cardiac injury, Zhou X, Fan GC, Ren X, Waggoner GR, Gregory KN, Chen G, Jones WK, Kranias EG, 2007 Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population, Zhao J, Zhou X, Huang J, Chen

Areas of Focus

Hypertension
Cardiomyopathy and heart failure
Cardiovascular metabolism

Publications

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment, Ganesh S, Zhong P, Zhou X, 2022
Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages, Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, Yuan X, Liu L, Yang J, Zhou X, 2022
Additional Value of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events in Patients With Novel Coronavirus Disease 2019 (COVID-19), Li S, Wang X, Hu H, Xu J, He J, Yang W, He B, Liu Y, Yu H, Zhou Q, Zhang H, Liu T, Hu K, Zhao Y, Huang Z, Zhu H, Zhang B, Zhao S, Sirajuddin A, Arai AE, Chen J, Zhou X, Lu M, 2021
The prognostic value of myocardial injury in COVID-19 patients and associated characteristics, He J, Zhang B, Zhou Q, Yang W, Xu J, Liu T, Zhang H, Wu Z, Li D, Zhou Q, Yan J, Zhang C, Qian H, Lu M, Zhou X, 2021
Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application, Zhang S, Zhou X, Chen Y, Wang L, Zhu B, Jiang Y, Bu P, Liu W, Li D, Li Y, Tao Y, Ren J, Fu L, Li Y, Shen X, Liu H, Sun G, Xu X, Bai J, Zhang W, Cai J, 2021
Effects of the total physical activity and its changes on incidence, progression, and remission of hypertension, Cai C, Liu FC, Li JX, Huang KY, Yang XL, Chen JC, Liu XQ, Cao J, Chen SF, Shen C, Yu L, Lu FH, Wu XP, Zhao LC, Li Y, Hu DS, Huang JF, Zhou XY, Lu XF, Gu DF, 2021
Relationship between the ABO Blood Group and the COVID-19 Susceptibility, Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG, 2021
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients, Wu Z, Hu R, Zhang C, Ren W, Yu A, Zhou X, 2020
Clinical characteristics of 82 cases of death from COVID-19, Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, Song Q, Jia Q, Wang J, 2020
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19, Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B, Wang J, 2020
Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity, Liu Y, Duan C, Liu W, Chen X, Wang Y, Liu X, Yue J, Yang J, Zhou X, 2019
Glabridin prevents Doxorubicin-induced cardiotoxicity through gut microbiota modulation and colonic macrophage polarization in mice, Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X, 2019
Frontline Science: Reprogramming COX-2, 5-LOX, and CYP4A-mediated arachidonic acid metabolism in macrophages by salidroside alleviates gouty arthritis, Liu Y, Tang H, Liu X, Chen H, Feng N, Zhang J, Wang C, Qiu M, Yang J, Zhou X, 2019
Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis, Chen G, Zhou X, Florea S, Qian J, Cai W, Zhang Z, Fan GC, Lorenz J, Hajjar RJ, Kranias EG, 2010
The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure, Chen G, Zhou X, Pathak A, Dorn GW, Kranias EG, 2009
Overexpression of histidine-rich ca-binding protein protects against ischemia/reperfusion-induced cardiac injury, Zhou X, Fan GC, Ren X, Waggoner GR, Gregory KN, Chen G, Jones WK, Kranias EG, 2007
Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population, Zhao J, Zhou X, Huang J, Chen

Blood Pressure Heart Disease Cardiac Function Metabolic Syndrome Clinical Trials Epidemiology Treatment Strategies Drug Therapy Patient Care Health Technology

Chao Shengping - Wuhan University

Fang Zhao - Wuhan University

Yan Ming - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us